dougie...from the Mop & Pail today, Dougie's new ceiling:
* Sernova Corp. (SVA-X) with a “speculative buy” rating and $2.50 target, matching the average on the Street.
“The stock is up 554 per cent since we initiated coverage in early December of 2020 and our price target corresponds to a one-year return of 29.5 per cent,” he said. “The firm’s core technology to which we ascribe market value is still Cell Pouch, a subcutaneously-implantable and vascularizable cell reservoir for preserving function of regenerative cell therapies deployed within it including but not limited to insulin-producing pancreatic islets. The firm has already published impressive preclinical data and for which ongoing clinical testing in a seven-patient Phase I/II hypoglycemia unawareness trial at the University of Chicago has already generated equally-impressive interim safety/efficacy data.”